What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Pathology
His primary scientific interests are in Pathology, Prostate cancer, Carcinoma, Cancer and Surgery.
His biological study spans a wide range of topics, including Urinary bladder and Adenocarcinoma.
His Prostate cancer study is concerned with the field of Internal medicine as a whole.
His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology and Oncology.
The study incorporates disciplines such as Bladder cancer, Transitional cell carcinoma and Multilocular Cystic Renal Cell Carcinoma in addition to Carcinoma.
His work deals with themes such as Cancer research and Evidence-based medicine, which intersect with Cancer.
His most cited work include:
- The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia (680 citations)
- Bladder cancer: Epidemiology, staging and grading, and diagnosis (634 citations)
- 2004 WHO Classification of the Renal Tumors of the Adults (611 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Pathology, Prostate cancer, Internal medicine, Oncology and Prostate.
His studies in Pathology integrate themes in fields like Intraepithelial neoplasia, Urinary bladder and Adenocarcinoma.
His Prostate cancer research is within the category of Cancer.
Many of his studies involve connections with topics such as Cancer research and Cancer.
His Oncology study incorporates themes from Clinical trial and Immunotherapy.
His Prostate study frequently links to other fields, such as Hyperplasia.
He most often published in these fields:
- Pathology (42.26%)
- Prostate cancer (31.05%)
- Internal medicine (28.57%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (28.57%)
- Prostate cancer (31.05%)
- Oncology (23.81%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Prostate cancer, Oncology, Pathology and Cancer research.
His Internal medicine study is mostly concerned with Renal cell carcinoma, Cancer, Radiation therapy, Quality of life and Biomarker.
The Prostate cancer study combines topics in areas such as Grading, Prostate and Radiology.
His Oncology study also includes
- Bladder cancer that intertwine with fields like Pathological,
- PD-L1 which is related to area like Urothelial carcinoma.
He mostly deals with Carcinoma in his studies of Pathology.
His research integrates issues of Biopsy and Clinical significance in his study of Prostatectomy.
Between 2017 and 2021, his most popular works were:
- Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers (159 citations)
- Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). (103 citations)
- Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies (81 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Internal medicine, Oncology, Prostate cancer, Immunotherapy and Renal cell carcinoma.
His research in Internal medicine focuses on subjects like MEDLINE, which are connected to Radiation therapy, Chromophobe Renal Cell Carcinoma, Treatment outcome and Combination immunotherapy.
His Oncology study combines topics in areas such as Pembrolizumab, Atezolizumab, Bladder cancer, Clinical trial and Biomarker.
His Prostate cancer study combines topics from a wide range of disciplines, such as Grading, Prostate and Genitourinary system.
His Carcinoma study contributes to a more complete understanding of Pathology.
He usually deals with Pathology and limits it to topics linked to Multivariate analysis and Phenotype.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
